Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2005, p. 8683-8692, Vol. 25, No. 19
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.19.8683-8692.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
and
Ramón Serrano
Instituto de Biología Molecular y Celular de Plantas, Universidad Politécnica de Valencia-CSIC, 46022 Valencia, Spain
Received 3 May 2005/ Returned for modification 27 May 2005/ Accepted 5 July 2005
|
|
|---|
|
|
|---|
The important roles of cellular H+ and K+ concentrations raise the unanswered question of whether these parameters are used as second messengers of external signals or are simply maintained within permissive ranges for the functionality of sensitive cellular systems (6, 21, 24, 39, 54). In any case, the regulation of H+, Na+, and K+ transport is crucial for cellular physiology, and defects in these systems have a wide array of consequences in medicine and agriculture, which range from diseases related to the nervous system, muscle, kidney, and heart (42) to sensitivity to low-pH and high-Na+ environments of agriculturally important crop plants (51, 52).
The remarkable capability of living cells to adjust intracellular H+ is not completely understood. Known mechanisms include the pH dependence of H+ transporters, such as the bacterial (40) and animal (58) Na+/H+ exchangers, and the activation of the animal Nhe1 exchanger by a mitogen-activated protein kinase cascade in response to growth factors (5).
In the yeast Saccharomyces cerevisiae, a model system for ion homeostasis studies (52), intracellular-pH regulation is partially explained by the pH dependence of the plasma membrane H+-pumping ATPase, Pma1p (49). This major transport system has an optimal pH of 6.5 and therefore is well suited to set the intracellular pH at a neutral value (14). However, the activity of the enzyme is regulated by glucose metabolism (which promotes acidification and fast growth) and by acid pH, suggesting an additional mechanism of pH regulation based on some unknown pH sensor that modulates the phosphorylation and activity of the ATPase (4). In addition, the activity of the major K+ transporters, Trk1p and Trk2p, are important to set the intracellular pH. H+ pumping by Pma1p is electrogenic, and K+ transport via Trk1p (and/or Trk2) is the major return current in yeast. Therefore, the regulation of Trk activity affects not only intracellular K+ and turgor (35), but also electrical membrane potential (32, 36) and intracellular pH (32, 61).
Genetic and phenotypic analyses have identified several proteins implicated in the regulation of potassium transport in yeast, including the protein phosphatases Ppz1p, Ppz2p, and calcineurin; the protein kinases Hal4p, Hal5p, and Sky1p; a protein of unknown function, Hal1p; and the G protein of the Ras superfamily, Arl1p (17, 34, 36, 38, 44, 61). The exact mechanisms of action of these proteins with respect to potassium homeostasis are largely unknown, but some have been suggested to directly regulate the activity of the Trk1p transporter (Hal4p, Hal5p, and calcineurin), while others appear to act indirectly (Hal1p, Sky1p, and Arl1p).
In the case of the Ppz phosphatases, several lines of evidence indicate that these proteins are involved in determining the upper limits of potassium accumulation in the cell in a largely (but not exclusively) Trk1p-dependent manner (35, 45, 47, 61). This alteration in the regulation of potassium transport dramatically affects the internal pH homeostasis due to the strict requirement for maintaining electrical neutrality during H+ pumping by the Pma1p ATPase. Specifically, in the ppz1 and -2 mutant grown under normal conditions, potassium accumulates and the internal pH is increased by approximately 0.4 pH units (61).
Protein phosphatases are often associated with regulatory subunits that provide substrate specificity, determine subcellular localization, or modulate the activity of the enzyme. To date, only one type of regulatory subunit has been described as regulating the activity of the Ppz phosphatases in vivo: Hal3p and a less active homologue encoded by the VHS3 gene (10, 46). The HAL3 gene was identified several years ago based on its impact on both toxic-cation tolerance and cell cycle progression (11, 16). It was then shown, in vitro and in vivo, to be a negative regulatory subunit of the Ppz phosphatases, thus explaining the observed phenotypes associated with the overexpression or disruption of the HAL3 gene (10, 47). However, little information is available regarding the physiological role and the nature of the signal transduced by the Ppz1-Hal3 regulatory complex.
Due to the important implications of the Trk1- and -2-dependent effects observed in turgor, internal pH homeostasis, and cell cycle progression for the ppz1 and -2 mutant, we have investigated whether the Ppz1p phosphatase binds to and modulates the phosphorylation levels of the Trk1p transporter. Furthermore, we present evidence for a novel mechanism of regulation of the activity of the Trk1p transporter based on a pH-dependent interaction of the Ppz1p phosphatase with its inhibitory subunit, Hal3p. The model that is suggested by previous reports and data presented here contends that Trk1p has a higher activity when phosphorylated in vivo and that Ppz1p decreases the phosphorylation levels of this transporter when potassium levels are high to avoid overaccumulation. This deactivation mechanism appears to be triggered by increases in the internal pH, which destabilize the interaction between Ppz1p and its inhibitory subunit, Hal3p, suggesting that the Hal3-Ppz1 complex acts as a pH sensor within the cell.
|
|
|---|
Plasmids and gene insertions. The inducible, hemagglutinin (HA)-tagged version of TRK1 was constructed by inserting a PCR-generated 1.7-kb NH2-terminal fragment into pBluescript using a primer-derived XhoI site and the endogenous PstI site and subsequently cloning a 2.0-kb COOH-terminal fragment using the endogenous PstI site and a primer-derived NotI site. The TRK1 coding sequence was then excised as a PmeI/NotI fragment and inserted into the pCM262 vector. This vector is derived from pCM190 (20), and it contains tetracycline-regulatable promoter and three copies of the HA epitope fused to the COOH terminus of the target gene. Expression was reduced to minimal levels by the addition of doxycycline (Sigma) to a final concentration of 20 µg/ml. A centromeric version of the Trk1-HA fusion was constructed using a similar two-step cloning strategy but replacing the synthetic restriction sites at the ends with SpeI and NdeI and inserting this fragment into a modified version of YCp414 lacking the N-ubiquitin sequence (27, 55). The same vector was digested with SalI and XhoI, and a PCR-generated fragment corresponding to the ORF of green fluorescent protein (GFP) was inserted in frame to generate the Trk1-GFP fusion protein. The strategy used for the construction of the GFP fusion of Ppz1p was based on that reported by Venturi et al. (56).
Flotation gradients and raft isolation. Flotation gradients to purify raft proteins were performed essentially as described previously (3). The modified fractionation experiments were identical, except that extracts, treated or not with Triton X-100 as indicated, were subjected to only one round of centrifugation for 4 h at 200,000 x g. In both cases, fractions were taken from the top and proteins were precipitated with trichloroacetic acid for analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Western blots were performed using the monoclonal 12CA5 anti-HA antibody (Roche Molecular Biochemicals), anti-Pma1p (50), anti-Hal3p (16), or anti-Ppz1p rabbit polyclonal antibodies (8). Immunoreactive bands were visualized using the ECL-Plus chemiluminescence system and horseradish peroxidase-conjugated secondary antibodies (Amersham).
Fluorescence microscopy. Fluorescence images were obtained for live cells grown to exponential phase in minimal medium using a Leica TCS SL inverted confocal microscope with a 40x/1.25-numerical-aperture planapochromat oil objective. Excitation was at 488 nm, and detection was between 500 and 530 nm. Vacuolar membranes were stained using the FM4-64 vital stain (Molecular Probes) according to the previously reported protocol (57). Excitation was at 488 nm, and detection was between 620 and 660 nm.
Immunoprecipitation of Trk1p and coimmunoprecipitation of Trk1p and Ppz1p. The immunoprecipitation of the Trk1-HA fusion protein was carried out overnight, using the anti-HA high-affinity antibody (Roche) and protein G- agarose (Roche). For in vitro kinase assays, extracts were prepared by vortexing (in the presence of glass beads) cell pellets resuspended in RIPA buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 0.1% SDS, 1% [wt/vol] deoxycholic acid [sodium salt; Sigma], 1% Triton X-100, and protease inhibitor cocktail [Roche]). For coimmunoprecipitation experiments, cell pellets (10 to 12 optical density at 66 nm [OD660] units) were resuspended in phosphate-buffered saline (supplemented with protease inhibitor cocktail [Roche]) and vortexed in the presence of glass beads. Insoluble material was removed by centrifugation for 5 min at 500 x g (2,000 rpm). Cross-linking was performed using dithiobis[succinimidylpropionate] (Pierce Biotechnology) as described by the manufacturer. The insoluble material was collected and homogenized in TNEGlyc buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 2 mM EDTA, 10% glycerol, protease inhibitor cocktail [Roche]). Proteins were solubilized by incubating them with 3 mM Zwittergent TM314 (Calbiochem) for 15 min at 28°C, and immunoprecipitations of the soluble material were carried out as described above. Identical experiments were conducted for the immunoprecipitation of Nha1p (strain MAP 73) (Table 1) and the myc-tagged versions of both Trk1p and Cch1p (strains AM300 and ELY242, respectively), except that where indicated, 3 µg of anti-myc (clone 9E10; Roche) was used in place of anti-HA.
|
View this table: [in a new window] |
TABLE 1. Yeast strains used in this study
|
-32P]ATP [Amersham]), with or without the addition of 50 mM EDTA, and incubated for 30 min at 28°C. The proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were exposed overnight to visualize the incorporated 32P and then processed for Western analysis as described above using the 12CA5 anti-HA antibody. In vivo labeling. The indicated strains were grown in low-phosphate medium (50 ml/strain) to an OD660 of 0.4. Cells were collected by centrifugation and resuspended in 5 ml of low-phosphate medium, 250 µCi of [32P]orthophosphate (Amersham) was added, and incubation was continued for 1 h at 28°C with rotation. Cell pellets were collected by centrifugation and then lysed and processed for raft purification as described above. After the second flotation gradient, the lightest density fraction was precipitated with trichloroacetic acid, resuspended in Laemmli sample buffer, and separated on 8% SDS-PAGE. Gels were dried and exposed to X-ray film for 30 min to 1 h.
In vitro binding and phosphatase assays. In vitro binding assays and phosphatase assays were performed as described previously, except that 50 mM BIS-TRIS {[bis-(2-hydroxyethyl)-imino]-tris-(hydroxymethyl)-methane}, (pKa, 6.5; CalBiochem) was used to buffer the pH of the interaction and reaction buffers (19).
Fractionation assays. The indicated yeast strains were grown in rich media adjusted to the indicated pH to an OD660 of 0.5 to 0.6, and cells were harvested by centrifugation and frozen at 70°C. The cells were resuspended in homogenization buffer (50 mM Tris, pH 8.0, 0.1 M KCl, 5 mM EDTA, 5 mM dithioerythritol, 20% sucrose [wt/vol], protease inhibitor cocktail) and lysed by vortexing them with glass beads. The lysate was collected after centrifugation for 5 min at 500 x g (2,000 rpm). The crude extract was separated into soluble and particulate fractions by centrifugation for 30 min at 30,000 rpm in a Ti70 rotor (Beckman). The particulate fraction was resuspended by homogenization. Approximately 50 µg of protein/lane was separated on 8% SDS-PAGE. The immunodetection of Hal3p was conducted as described above.
|
|
|---|
Lipid rafts are operationally defined as protein-lipid complexes of low buoyant density that are resistant to extraction with nonionic detergents, such as Triton X-100, at low temperatures. These plasma membrane microdomains can be highly purified by applying Triton-treated extracts to flotation gradients. To determine whether Trk1p is present in rafts, we employed a strain harboring an inducible plasmid encoding TRK1 fused to three tandem copies of the HA epitope at the COOH terminus. Since the overproduction of protein products is known to produce artifacts in subcellular-localization assays, fractionation experiments were performed under conditions where the TRK1-HA fusion was expressed at very low levels (in the presence of 20 µg/ml of doxycycline). We observed that both the Trk1-HA fusion protein and Pma1p were highly enriched in the lightest density fractions, corresponding to the purified lipid rafts (Fig. 1). We subsequently confirmed this lipid raft association for Trk1p expressed from a centromeric plasmid under the control of the ADH1 promoter or under the control of its own promoter by using a genomically tagged version of TRK1 (strains LY 236 and AM300) (data not shown). These results establish Trk1p as yet another yeast transporter present in lipid rafts. Interestingly, a previous report suggested that Trk2p is also present in these microdomains, although in that case, the protein was highly overexpressed, complicating the interpretation of these data (62).
![]() View larger version (30K): [in a new window] |
FIG. 1. Trk1p is localized to plasma membrane rafts. Rafts were purified from the W 3 [pCM262-TRK1] yeast strain (grown in the presence of 20 µg/ml doxycycline) as described in Materials and Methods. The presence of Pma1p and the HA-tagged version of Trk1p in the various fractions was analyzed by Western blotting. Identical results were observed in four different experiments. The numbers above the lanes indicate the fraction number starting from the top of the gradient (lowest to highest density).
|
![]() View larger version (31K): [in a new window] |
FIG. 2. Localization of the Ppz1-GFP fusion protein. The strains LY 166 and LY 247 were analyzed by confocal microscopy, as described in Materials and Methods. The localization of the fusion proteins is shown in green. The FM4-64-stained vacuolar membranes are shown in red. Overlay and gray scale images are also shown.
|
![]() View larger version (53K): [in a new window] |
FIG. 3. Ppz1p partially associates with the lowest-density fraction in flotation gradients. Proteins were extracted from the W303-1A strain and processed as described in Materials and Methods. The Ponceau S staining of the membranes is shown in the top panel, as a control for protein loading. Fraction numbers are indicated above each lane (1 indicates the lowest-density and 8 indicates the highest-density fraction).
|
![]() View larger version (51K): [in a new window] |
FIG. 4. Redistribution of Ppz1p upon TRK1 overexpression. The indicated yeast strains (W 3, W303-1A, LY 152, and LY 161) were processed for flotation gradients as described in Materials and Methods. The top row shows the Ponceau S staining of the membranes as a control for protein loading. The amount of Ppz1p in each lane was estimated in digitally converted images using the MacBAS software. The LY 161 strain was grown in the presence (uninduced) or absence (induced) of doxycycline (20 µg/ml) to control TRK1 expression. Similar results were observed in two separate experiments. WT, wild type.
|
![]() View larger version (33K): [in a new window] |
FIG. 5. Ppz1p coimmunoprecipitates with Trk1p. Proteins were extracted from the indicated yeast strains, cross-linked, and processed for immunoprecipitation experiments as described in Materials and Methods. The proteins recovered by the affinity resin were analyzed by Western blotting using the indicated antibodies. In panel A, the first two lanes contain an aliquot of the crude extracts, and the last two lanes contain the immunoprecipitated material. In panels B and C, the lanes correspond to the immunoprecipitated material from the indicated strain.
|
-32P]ATP (Fig. 6A). The radioactive labeling of Trk1p is largely inhibited by the addition of EDTA, suggesting that, as expected, it is the result of an Mg2+-dependent chemical reaction catalyzed by an endogenous kinase associated with Trk1p. Studies are under way to identify this kinase.
![]() View larger version (47K): [in a new window] |
FIG. 6. Phosphorylation of Trk1p in vitro and in vivo. (A) Proteins extracted from the yeast strain LY 236 were processed for immunoprecipitation experiments, followed by in vitro kinase assays, as described in Materials and Methods. On top are shown the results of the autoradiography, and the results of the Western blot used as a control of protein loading are below. Similar results were observed in three separate experiments. (B) The indicated strains were grown in low-phosphate media, and phosphorylated proteins were radioactively labeled in vivo and processed for raft purification, as described in Materials and Methods. Proteins present in the top fraction of the second gradient were separated by SDS-PAGE and analyzed by autoradiography (top). On the bottom is a Ponceau S-stained membrane showing equal amounts of protein present in each sample extracted just before labeling. Similar results were observed in three different experiments. WT, wild type.
|
In addition, we observed increased phosphorylation of this high-molecular-mass band in strains overexpressing HAL5 (Fig. 6B, lane 4). This gene encodes a kinase genetically established as a positive regulator of Trk1p activity (36). These results demonstrate increases in the steady-state phosphorylation levels of Trk1p in strains lacking PPZ1 and PPZ2 or overexpressing HAL5. The observed increase in Trk1p phosphorylation in the ppz1 and -2 mutant cannot be explained by increased transcription of the gene encoding the transporter or accumulation of the protein, as no changes in gene expression or protein levels were detected for TRK1 in Ppz-deficient strains (data not shown).
The interaction between Hal3p and Ppz1p is pH responsive. Having established a physical interaction between Ppz1p and Trk1p and modulation of Trk1p phosphorylation levels in ppz1 and -2 mutants, we were further interested in investigating how Ppz1p may be regulated under physiological conditions. Several lines of evidence have established Hal3p as a negative regulator of the Ppz phosphatases (10, 47). Based on the marked increase in the internal pH of the ppz1 and -2 mutant and our proposed model for Ppz1p function, we reasoned that the activity of this phosphatase would be vital when the internal pH increases (61). Therefore, we investigated the possibility that the interaction between Hal3p and Ppz1p may be affected by pH. In vitro binding experiments were performed using the catalytic domain of Ppz1p fused to glutathione-S-transferase (GST), as this domain was previously reported to be sufficient for Hal3p binding (10). As shown in Fig. 7A, much more Hal3p can be retained by the Ppz1p-containing affinity resin at pH 6.0 than at pH 7.5. The specificity of this modulation in the Hal3-Ppz1 interaction was investigated by comparing the interaction profile of the catalytic domain of Ppz1p with that of Ypi1p. The Ypi1 protein is a recently identified inhibitor of the protein phosphatase Glc7p capable of binding both Glc7p and Ppz1p in vitro (19). As shown in Fig. 7A, Ypi1p appears to have a slightly higher affinity for Ppz1p at pH 7.5 versus pH 6, suggesting that the differences observed for Hal3p and Ppz1p are not the result of nonspecific changes in the binding interaction due to the change in pH employed. Further experiments over a larger pH range (5.5 to 7.5) showed that maximal Hal3p binding was observed at pH 6.0 (Fig. 7B). This observation was further supported by results obtained using in vitro phosphatase assays, in which we observed that the Hal3p-mediated inhibition of Ppz1p activity was markedly decreased at pH 7.5 compared to pH 6 (Fig. 7C).
![]() View larger version (27K): [in a new window] |
FIG. 7. The in vitro interaction between Ppz1p and Hal3p is pH dependent. (A) Representative Western blot showing the amount of Hal3p (top) or Ypi1p (bottom) bound by the Ppz1 N-GST affinity resin at the pH indicated and the amount of Hal3p or Ypi1p in the starting extracts (input). The specificity of the binding interactions is demonstrated by the lack of binding to GST alone. Ponceau S-stained nitrocellulose membranes demonstrating equal protein loading are shown. The positions of GST and the Ppz1 N-GST fusion protein are indicated. Similar results were observed in two different experiments. (B) The same experiment as in panel A was performed at the indicated pHs. Shown are Western analysis with Hal3p-specific antibodies of the starting material (top) and the affinity-purified material (middle) and the Ponceau S-stained nitrocellulose membrane (bottom). (C) In vitro phosphatase assays were performed as described in Materials and Methods. The results are expressed as the percentage of phosphatase activity observed in the absence of Hal3p and represent the average of duplicate determinations (diamonds, pH 6.5; squares, pH 7.0; triangles, pH 7.5).
|
![]() View larger version (63K): [in a new window] |
FIG. 8. The pH dependence of the Ppz1-Hal3 interaction can be observed biochemically and phenotypically in vivo. (A) The amount of Hal3p recovered in the insoluble fraction was assayed as described in Materials and Methods. (Top) Representative Western analysis of the amount of Hal3p present in the indicated fractions. (Bottom) Ponceau S staining of the nitrocellulose filter as a control for equal protein loading in comparable fractions. (B) The indicated strains (LY 78, LY 79, and LY 83) were grown to saturation in rich media, serially diluted in water, and spotted on the indicated solid media. Growth was recorded after 48 to 72 h of incubation at 28°C.
|
![]() View larger version (56K): [in a new window] |
FIG. 9. Both Hal3p and the Ppz phosphatases are involved in the adaptation of yeast cells to acidic pH. The indicated strains were grown to saturation in rich media, serially diluted in water, and spotted on the indicated solid media. Growth was recorded after 48 to 72 h of incubation at 28°C. WT, wild type.
|
|
|
|---|
In this report, we provide evidence for a pH-responsive, phosphorylation-dependent regulation of the Trk1p potassium transporter. Our results suggest that the activity of the Trk1p transporter is increased by phosphorylation. As Trk1p is known to have two activity (and affinity) states, phosphorylation of the transporter may be involved in this switch, as has been previously proposed (25). Another possibility is that the phosphorylation of Trk1p controls transporter trafficking and/or stability, as has been described for other yeast plasma membrane proteins, like Gap1 (9). Both of these possibilities are under investigation.
A genetic link between the Ppz phosphatases and the Trk potassium transporters has been established (35, 61). The majority of the phenotypes observed for the ppz1 and -2 mutant, including that associated with cell cycle progression, depend on the presence of the TRK1 and TRK2 genes. Here, we report the subcellular localization of the phosphatase at the plasma membrane, the physical interaction between Ppz1p and Trk1p by both immunoprecipitation and fractionation techniques, and the increased in vivo phosphorylation of Trk1p in ppz1 and -2 strains. Although we do not discard the existence of additional Ppz substrates, many lines of evidence, including Rb+ uptake and K+ accumulation measurements, potassium sensitivity phenotypes, and increases in internal pH, suggest that the Ppz1p phosphatase acts to down-regulate the activity of the Trk1p potassium transporter by modulating its phosphorylation state. The data presented here do not unequivocally identify Trk1p as a direct substrate for Ppz1p, although all of the results presented are consistent with this hypothesis. However, the results of the in vitro kinase assays suggest that several interacting proteins are present in the Trk1p immunoprecipitate. Therefore, we cannot rule out the possibility that Ppz1p acts on one or more proteins present in this complex in order to modify the phosphorylation state of Trk1p.
Studies to identify both the specific phosphorylation sites and the kinase associated with the Trk1p transporter are under way but will be technically challenging. Trk1p is a large protein with a calculated molecular mass of 140 kDa (apparent molecular mass in SDS-PAGE, 180 kDa) that is not highly expressed. Structural modeling suggests that it adopts a 4-MPM channel-like conformation and that it contains intracellular extensions at both the NH2 and COOH termini and three intracellular loops of various lengths (12). There are more than 80 serine and threonine residues within these domains that are predicted phosphorylation sites (NetPhos 2.0 prediction software CBS; Technical University of Denmark). However, attempts to phosphorylate the cytosolic domains individually as GST fusion proteins in vitro or in vivo have been unproductive so far (L. Yenush, unpublished data). These results suggest that localization to the plasma membrane and/or the tertiary structure of the protein may be required for interaction with the kinase.
There are several obvious candidate Trk1p kinases, including Hal4p, Hal5p (36), Sky1p (17), and Hog1p, which was recently shown to phosphorylate Nha1p and Tok1p (43). Biochemical studies are in progress to investigate the role of each of these kinases in the regulation of Trk1p. Our results show that more phosphorylated Trk1p is observed upon HAL5 overexpression, but the levels of the other phosphorylated proteins, including Pma1p, are also increased, suggesting that other approaches are necessary to clarify the physiological role of Hal5p in Trk1p regulation. Interestingly, in preliminary experiments, very low levels of phosphorylation of all four raft-associated proteins were observed in strains lacking both HAL4 and HAL5 (L. Yenush, unpublished observations). Studies are under way to investigate this important point.
One of the novel aspects of the results reported here is the pH-responsive component of this regulatory mechanism of potassium homeostasis. To our knowledge, this is the first example of the interaction between a phosphatase and an inhibitory subunit responding to changes in pH. The molecular details of how changes in pH regulate this interaction will require analysis of the atomic structure of the protein complex. Recent mutagenesis analysis of Hal3p has identified a complex interaction between Hal3p and Ppz1p (37). Although many of the Hal3p residues identified as being important for the interaction map to a region of approximately 30 amino acids, the profile of Ppz1p inhibition of these mutations is not straightforward and suggests a complex interaction between the two proteins. In any case, the observation that this system is regulated by increases in internal pH makes intuitive sense; as potassium accumulates in the cytosol, the internal pH will increase as protons are extruded in order to maintain electrical neutrality. However, as mentioned earlier, accumulation of potassium can be very detrimental to the cell, causing a large increase in turgor pressure and the risk of cell lysis. Therefore, the cell can use this concomitant increase in intracellular pH to signal the down-regulation of potassium transport. In the model presented here, this mechanism would involve the destabilization of the interaction between Hal3p and Ppz1p at relatively alkaline pH, thus allowing the phosphatase to act on Trk1p and decrease the potassium uptake into the cell. Our experiments with the Ppz1-GFP fusion protein suggest that this phosphatase is localized at the plasma membrane under normal growth conditions and that this localization pattern is not changed by varying the external pH or by removing TRK1 and TRK2 (data not shown). These results may suggest that the key regulatory step is the Hal3p-Ppz1p interaction and would provide a rapid response mechanism to quickly inhibit high-affinity potassium uptake in response to transient increases in pH.
Studies of transporters similar to Trk1p, like the HKT transporters from plants, will reveal if this phosphorylation-dependent mechanism for maintaining potassium homeostasis is conserved evolutionarily and whether this process is influenced by pH. As these plant transporters are proposed to be important determinants of salinity tolerance, elucidation of these types of regulatory mechanisms will have an important impact in agricultural biotechnology (33, 48). Similarly, since the regulation of both potassium transport and internal pH homeostasis has been implicated in a wide range of diseases, including cancer, investigation of similar signal transduction pathways connecting pH and potassium homeostasis represents an exciting area of investigation (53).
We thank Joaquin Ariño for providing Ppz1p antibodies; Kyle Cunningham, Markus Proft, Pascual Sanz, and Anne Rosenwald for providing yeast strains and plasmids; and Dolores Bernal and José Ramón Murguía for helpful discussions. We also thank María Dolores Gómez and Huw Jenkins for excellent technical assistance with the confocal microscopy.
Present address: Warwick Horticulture Research International, Wellesbourne, Warwick, CV35 9EF, United Kingdom. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»